NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
25 juin 2024 09h00 HE | NeuroOne Medical Technologies Corp
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation
20 juin 2024 09h30 HE | NeuroOne Medical Technologies Corp
ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF™ Ablation System for broader adoption and...
logo.png
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE
10 juin 2024 10h50 HE | GlucoTrack, Inc.
Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...
logo.png
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
05 juin 2024 08h30 HE | GlucoTrack, Inc.
Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90 Continuous blood glucose monitor offers the potential for simplified, discreet...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
14 mai 2024 16h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces First Quarter 2024 Results
13 mai 2024 09h15 HE | Sanara MedTech Inc.
FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
10 mai 2024 14h43 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
29 avr. 2024 09h15 HE | Sanara MedTech Inc.
FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
10 avr. 2024 09h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
09 avr. 2024 09h05 HE | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...